TCI Wealth Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TGTX
DGM
TCI Wealth Advisors's TGTX Position: Q2 2023 in Review
TCI Wealth Advisors sold out of TG Therapeutics (TGTX) in Q2 2023, closing a stake of 706 shares — an estimated $10.6K sold.
TCI Wealth Advisors first reported a position in TGTX in Q3 2017 and held it in 21 quarters. The position peaked at $16K in Q4 2020. 244 funds tracked by Wall St. Rank hold TGTX as of Q2 2023.
- TCI Wealth Advisors reported no remaining TG Therapeutics position as of Q2 2023 after selling out during the quarter.
- TCI Wealth Advisors sold 706 TG Therapeutics shares in Q2 2023, an estimated $10.6K.
- TCI Wealth Advisors first reported a position in TG Therapeutics in Q3 2017 and held it in 21 quarters.
- TCI Wealth Advisors's TG Therapeutics position peaked at $16K in Q4 2020.
- 244 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2023.
Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.